Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,001 | -70,780 | -63,675 | -57,924 | -50,315 |
| Depreciation Amortization | 5,045 | 3,633 | 3,046 | 2,526 | 3,025 |
| Accounts payable and accrued liabilities | -69 | -578 | 393 | -561 | 1,261 |
| Other Working Capital | -3,584 | -5,459 | -3,219 | -788 | -22 |
| Other Operating Activity | 6,913 | 14,039 | 11,744 | 10,941 | 6,810 |
| Operating Cash Flow | $-50,696 | $-59,145 | $-51,711 | $-45,806 | $-39,241 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,277 | -2,122 | -2,442 | -2,324 | -2,269 |
| Net Acquisitions | N/A | -760 | N/A | N/A | N/A |
| Purchase Of Investment | -72,490 | -86,278 | -112,892 | -186,591 | -221,795 |
| Sale Of Investment | 108,991 | 155,410 | 71,599 | 163,175 | 85,100 |
| Investing Cash Flow | $35,224 | $66,250 | $-43,735 | $-25,740 | $-138,964 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 335,409 |
| Common Stock Issued | 214 | 1,144 | 368 | 562 | 167 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -8,129 |
| Financing Cash Flow | $214 | $1,144 | $368 | $562 | $327,447 |
| Beginning Cash Position | 28,648 | 20,399 | 115,477 | 186,461 | 37,219 |
| End Cash Position | 13,390 | 28,648 | 20,399 | 115,477 | 186,461 |
| Net Cash Flow | $-15,258 | $8,249 | $-95,078 | $-70,984 | $149,242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,696 | -59,145 | -51,711 | -45,806 | -39,241 |
| Capital Expenditure | -1,277 | -2,122 | -2,442 | -2,324 | -2,269 |
| Free Cash Flow | -51,973 | -61,267 | -54,153 | -48,130 | -41,510 |